{"id":"https://openalex.org/W2606699740","doi":null,"title":"Are glycyrrhizin derivatives specific inhibitors of HMGB1/DNA interactions","display_name":"Are glycyrrhizin derivatives specific inhibitors of HMGB1/DNA interactions","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2606699740","mag":"2606699740"},"language":"en","primary_location":{"id":"mag:2606699740","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/are-glycyrrhizin-derivatives-specific-inhibitors-of-hmgb1dna-interactions.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075589850","display_name":"Sivakumar Annadurai","orcid":"https://orcid.org/0000-0001-7807-3742","observed_orcids":["https://orcid.org/0000-0001-7807-3742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sivakumar Annadurai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7807-3742","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088900927","display_name":"Daniel J. Canney","orcid":"https://orcid.org/0000-0003-2717-0328","observed_orcids":["https://orcid.org/0000-0003-2717-0328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Canney","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2717-0328","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069358855","display_name":"David B. Lebo","orcid":"https://orcid.org/0000-0001-5465-1376","observed_orcids":["https://orcid.org/0000-0001-5465-1376"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Lebo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009358670","display_name":"Natalia F. Krynetskaia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalia F. Krynetskaia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036222375","display_name":"Evgeny Y. Krynetskiy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evgeny Krynetskiy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42210118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"3","first_page":"470","last_page":"477"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.023600000888109207,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ammonium-glycyrrhizinate","display_name":"ammonium glycyrrhizinate","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glycyrrhetinic-acid","display_name":"glycyrrhetinic acid","score":0.8759999871253967},{"id":"https://openalex.org/keywords/carbenoxolone","display_name":"carbenoxolone","score":0.984000027179718},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dna-binding-inhibition","display_name":"DNA binding inhibition","score":0.7260000109672546},{"id":"https://openalex.org/keywords/triterpenoids","display_name":"triterpenoids","score":0.7170000076293945},{"id":"https://openalex.org/keywords/micellar-aggregation","display_name":"micellar aggregation","score":0.722000002861023},{"id":"https://openalex.org/keywords/enzyme-inhibition-specificity","display_name":"enzyme inhibition specificity","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7070788741111755},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.646049439907074},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6288607120513916},{"id":"https://openalex.org/C160160445","wikidata":"https://www.wikidata.org/wiki/Q24769688","display_name":"Alkaline phosphatase","level":3,"score":0.5982152223587036},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.5402348637580872},{"id":"https://openalex.org/C2778401398","wikidata":"https://www.wikidata.org/wiki/Q383836","display_name":"Chymotrypsin","level":4,"score":0.46587297320365906},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4463644027709961},{"id":"https://openalex.org/C2776332754","wikidata":"https://www.wikidata.org/wiki/Q418705","display_name":"Glycyrrhizin","level":2,"score":0.4333982467651367},{"id":"https://openalex.org/C2780340462","wikidata":"https://www.wikidata.org/wiki/Q127450","display_name":"Trypsin","level":3,"score":0.40979593992233276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18944156169891357},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07292619347572327}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2606699740","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/are-glycyrrhizin-derivatives-specific-inhibitors-of-hmgb1dna-interactions.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6826000213623047,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2034594119"],"related_works":["https://openalex.org/W2199537525","https://openalex.org/W2034594119","https://openalex.org/W3045163012","https://openalex.org/W2530757566","https://openalex.org/W2053560870","https://openalex.org/W2036278893","https://openalex.org/W4402223538","https://openalex.org/W2332785527","https://openalex.org/W7005969773","https://openalex.org/W2610869117"],"abstract_inverted_index":{"Previous":[0],"work":[1,106],"in":[2,26,28,81,126,149,181],"our":[3,167],"laboratory":[4],"investigated":[5],"the":[6,22,50,57,62,71,78,108,113,127,140,150,154,170,182],"ability":[7],"of":[8,52,89,112,115,184],"ammonium":[9],"glycyrrhizinate":[10],"(GLA)":[11],"and":[12,17,47,75,101,133,176],"two":[13],"related":[14],"compounds":[15,79,87],"(carbenoxolone":[16],"glycyrrhetinic":[18],"acid)":[19],"to":[20],"inhibit":[21,92,146],"DNA-binding":[23,51],"properties":[24],"HMGB1":[25,53],"an":[27],"vitro":[29],"screening":[30],"system":[31],"based":[32],"on":[33,190],"a":[34],"quantitative":[35],"capillary":[36],"electrophoresis":[37],"mobility":[38],"shift":[39],"assay":[40],"(CEMSA).":[41],"Our":[42,136],"results":[43,137],"demonstrated":[44],"that":[45,86,139,174],"GLA":[46,120,141,156,175],"GAK":[48,160,177],"inhibited":[49],"at":[54],"concentrations":[55],"above":[56],"critical":[58],"micelle":[59],"concentration.":[60],"Thus,":[61],"inhibitory":[63],"effects":[64,189],"were":[65,80,129],"observed":[66,118],"only":[67],"under":[68],"conditions":[69],"where":[70],"triterpenes":[72],"formed":[73],"aggregates":[74,91],"not":[76,145],"when":[77],"solution.":[82],"Literature":[83],"evidence":[84],"suggests":[85],"capable":[88],"forming":[90],"or":[93],"activate":[94],"unrelated":[95],"proteins":[96,124],"including":[97],"chymotrypsin,":[98],"b-lactamse,":[99],"b-galactosidase":[100],"alkaline":[102,134,162],"phosphatase.":[103,135,163],"The":[104,122],"present":[105,171],"investigates":[107],"possible":[109],"promiscuous":[110],"nature":[111],"inhibition":[114,183],"HMGB1/DNA":[116],"interactions":[117,186],"for":[119],"derivatives.":[121],"model":[123],"used":[125],"study":[128],"glutathione":[130],"Stransferase":[131],"(GST)":[132],"indicate":[138],"derivatives":[142],"tested":[143],"do":[144],"enzyme":[147],"activity":[148],"enzymes":[151],"tested.":[152],"On":[153],"contrary,":[155],"activated":[157,161],"GST":[158],"while":[159],"Taken":[164],"together":[165],"with":[166,187],"previous":[168],"results,":[169],"data":[172],"suggest":[173],"could":[178],"be":[179],"utilized":[180],"macromolecular":[185],"minimal":[188],"cellular":[191],"enzymes.":[192]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2017-04-28T00:00:00"}